It will be very interesting, IMO, to see and hear what our new BOD decides to do with all known clinical and biomarkers data extracted from Sunrise.
I understand and also am very curious but many crazy things have happened and with BOD change up possibly staged I don't know for sure the right things will be done for shareholders.